#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatitis D Hypoxic-ischaemic encephalopathy Pulmonary tuberculosis Paraneoplastic neurological syndrome Neoplasm malignant Epidermolysis bullosa Parkinson's disease Deafness neurosensory Angiosarcoma Muscular dystrophy Soft tissue necrosis Leukaemia Angiosarcoma non-metastatic Acute lymphocytic leukaemia recurrent KBG syndrome More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Life with Disease Pemphigoid – Basic Information Advanced systemic mastocytosis – Treatment Paraneoplastic neurological syndrome – Treatment Myelodysplastic syndrome Sjogren’s syndrome – Treatment Turner’s syndrome – Basic Information Congenital generalised lipodystrophy – Trials in Disease Richter’s syndrome – Basic Information Indolent systemic mastocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clemastine Fumarate Ephedrine Hydrochloride Daplusiran Nivolumab Ibrexafungerp BI-1607 Haloperidol Brimonidine RO7268489 Panitumumab Rapcabtagene Autoleucel Azathioprine Ticagrelor Piperacillin Bexmarilimab Sebetralstat Lisdexamfetamine Dimesylate Vesleteplirsen Sxr1096 Ly3484356 More therapies…

    Learn about Your Condition

    Mucous membrane pemphigoid Small for dates baby Rhabdomyosarcoma recurrent Peptostreptococcus infection Hypogonadism male Carotid artery stenosis Hypophosphatasia Non-obstructive cardiomyopathy Vascular calcification Head and neck cancer Pharyngeal cancer stage I Follicular lymphoma stage III Pseudomyxoma peritonei Portal hypertension Psychotic behaviour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

    Recruiting

    3 1
    Investigated Drugs:
    • ADX-324
    Austria Belgium Bulgaria Croatia Czechia France +5

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated Drugs:
    • Axatilimab
    Belgium Germany Italy Spain

  • Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

    Recruiting

    3 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Ruxolitinib
    Austria Belgium Bulgaria Denmark France Germany +6

  • Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Idarubicin Hydrochloride
    • Midostaurin
    • Mitoxantrone Hydrochloride
    France Germany Italy Poland

  • Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Linvoseltamab
    • Daratumumab
    • Dexamethasone
    Austria Belgium Croatia Czechia Denmark Estonia +10

  • Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • SAR444336
    Belgium Denmark France Germany Hungary Italy +2

  • Study of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • IMMUNOSTEM
    Italy

  • Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment

    Recruiting

    4 1 1
    Germany Italy The Netherlands Spain

  • Comparing piperacillin-tazobactam and meropenem for treating bloodstream infections caused by cephalosporin-resistant bacteria in adult patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacteraemia
    Investigated Drugs:
    • Meropenem Anhydrous
    • Piperacillin
    • Tazobactam
    Italy
Previous Page
1 … 4 5 6 7 8 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!